Published in Nucleic Acids Res on March 01, 2003
HIV-1 reverse transcription. Cold Spring Harb Perspect Med (2012) 1.29
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors. Viruses (2010) 1.06
High frequency of genetic recombination is a common feature of primate lentivirus replication. J Virol (2006) 0.94
Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription. J Virol (2003) 0.92
Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells. Antimicrob Agents Chemother (2005) 0.80
Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease. Virology (2013) 0.79
Fate of HIV-1 cDNA intermediates during reverse transcription is dictated by transcription initiation site of virus genomic RNA. Sci Rep (2015) 0.78
The reverse transcriptase of the Tf1 retrotransposon has a specific novel activity for generating the RNA self-primer that is functional in cDNA synthesis. J Virol (2008) 0.77
The dUTPase-related gene of bovine immunodeficiency virus is critical for viral replication, despite the lack of dUTPase activity of the encoded protein. Retrovirology (2014) 0.76
A Novel Leu92 Mutant of HIV-1 Reverse Transcriptase with a Selective Deficiency in Strand Transfer Causes a Loss of Viral Replication. J Virol (2015) 0.75
Coordination between the polymerase and RNase H activity of HIV-1 reverse transcriptase. Nucleic Acids Res (2017) 0.75
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science (1992) 14.70
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science (1998) 11.23
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP. Nature (1985) 8.46
Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science (1986) 6.53
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J (2001) 4.36
Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism. Science (1994) 4.11
Structure of the RNA-dependent RNA polymerase of poliovirus. Structure (1997) 3.88
Retroviral reverse transcriptase: synthesis, structure, and function. J Acquir Immune Defic Syndr (1990) 3.55
Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc Natl Acad Sci U S A (1988) 3.53
Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. J Mol Biol (1998) 3.14
Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J Virol (1992) 2.89
Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure (1995) 2.20
Structure of T7 RNA polymerase complexed to the transcriptional inhibitor T7 lysozyme. EMBO J (1998) 1.66
Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity. Biochemistry (2002) 1.64
Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors. Proc Natl Acad Sci U S A (2002) 1.60
Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J Biol Chem (1991) 1.43
Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli. Virology (1991) 1.16
The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits. J Mol Biol (2001) 1.04
The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J Biol Chem (1992) 1.03
Molecular dynamics of HIV-1 reverse transcriptase indicates increased flexibility upon DNA binding. Proteins (2001) 0.95
Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase. Biochemistry (1996) 0.89
Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase. AIDS Res Hum Retroviruses (1989) 0.79
Tomato SP-interacting proteins define a conserved signaling system that regulates shoot architecture and flowering. Plant Cell (2001) 2.11
Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization. Biochem J (1998) 2.03
HIV-1 reverse transcriptase: structure predictions for the polymerase domain. AIDS Res Hum Retroviruses (1990) 1.80
RNA-dependent DNA polymerase of avian sarcoma virus B77. I. Isolation and partial characterization of the alpha, beta2, and alphabeta forms of the enzyme. J Biol Chem (1977) 1.80
Mechanism of photoinhibition in vivo. A reversible light-induced conformational change of reaction center II is related to an irreversible modification of the D1 protein. J Biol Chem (1990) 1.45
Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J Biol Chem (1991) 1.43
HIV-1 reverse transcriptase purified from a recombinant strain of Escherichia coli. AIDS Res Hum Retroviruses (1990) 1.39
Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure. Virology (1990) 1.38
The RNA-dependent DNA polymerase of avian sarcoma virus B77. Binding of viral and nonviral ribonucleic acids to the alpha, beta2, and alphabeta forms of the enzyme. J Biol Chem (1977) 1.30
Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: mispair extension frequencies. Biochemistry (1992) 1.25
The fidelity of the reverse transcriptases of human immunodeficiency viruses and murine leukemia virus, exhibited by the mispair extension frequencies, is sequence dependent and enzyme related. FEBS Lett (1993) 1.21
RNA-dependent DNA polymerase of avian sarcoma virus B77. II. Comparison of the catalytic properties of the alpha, beta2, and alphabeta enzyme forms. J Biol Chem (1977) 1.14
Incorporation of the guanosine triphosphate analogs 8-oxo-dGTP and 8-NH2-dGTP by reverse transcriptases and mammalian DNA polymerases. J Biol Chem (1997) 1.13
Physiological parameters of prokaryotic metallothionein induction. Biochem Biophys Res Commun (1980) 1.08
Mutational studies of human immunodeficiency virus type 1 reverse transcriptase: the involvement of residues 183 and 184 in the fidelity of DNA synthesis. FEBS Lett (1996) 1.06
The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits. J Mol Biol (2001) 1.04
The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J Biol Chem (1992) 1.03
Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1990) 1.03
The fidelity of 3' misinsertion and mispair extension during DNA synthesis exhibited by two drug-resistant mutants of the reverse transcriptase of human immunodeficiency virus type 1 with Leu74-->Val and Glu89-->Gly. Eur J Biochem (1997) 1.03
The beta subunit of the DNA polymerase of avian sarcoma virus strain B77 is a phosphoprotein. Virology (1977) 1.02
Characterization of a protein, released by the T47D cell line, immunologically related to the major envelope protein of mouse mammary tumor virus. Proc Natl Acad Sci U S A (1985) 1.00
Prolactin synthesis by human chorion-decidual tissue: a possible source of prolactin in the amniotic fluid. Science (1978) 1.00
Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus. Biochemistry (1993) 1.00
The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses. J Biol Chem (1993) 0.99
Human monoclonal antibodies derived from lymph nodes of a patient with breast carcinoma react with MuMTV polypeptides. Cancer (1987) 0.99
The processivity of DNA synthesis exhibited by drug-resistant variants of human immunodeficiency virus type-1 reverse transcriptase. Nucleic Acids Res (1998) 0.98
Studies on the amino acid sequence content of proteins specified by the gag and pol genes of avian sarcoma virus B77. Virology (1978) 0.96
The inhibition of the reverse transcriptase of HIV-1 by the natural sulfoglycolipids from cyanobacteria: contribution of different moieties to their high potency. J Nat Prod (1998) 0.96
New acylated sulfoglycolipids and digalactolipids and related known glycolipids from cyanobacteria with a potential to inhibit the reverse transcriptase of HIV-1. J Nat Prod (1997) 0.94
Fidelity of the reverse transcriptase of human immunodeficiency virus type 2. FEBS Lett (1992) 0.93
The inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivatives. FEBS Lett (1990) 0.93
The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2. AIDS Res Hum Retroviruses (1991) 0.93
Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs. J Biol Chem (1999) 0.92
Two newly identified membrane-associated and plastidic tomato HXKs: characteristics, predicted structure and intracellular localization. Planta (2006) 0.92
Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens. Proc Natl Acad Sci U S A (1989) 0.92
Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer. J Mol Biol (1997) 0.91
Polycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerases. Biochem J (1999) 0.91
On the mechanism of glucose-6-phosphate dehydrogenase regulation in mouse liver. 3. The rate of enzyme synthesis and degradation. Eur J Biochem (1974) 0.90
On the mechanism of glucose-6-phosphate dehydrogenase regulation in mouse liver. 1. Characterization of the system. Eur J Biochem (1974) 0.90
Inefficient repair of RNA x DNA hybrids. Eur J Biochem (1997) 0.90
A viral antigen as a marker for the prognosis of human breast cancer. Eur J Cancer Clin Oncol (1982) 0.87
Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7. J Biol Chem (2000) 0.87
Catalytic features of the recombinant reverse transcriptase of bovine leukemia virus expressed in bacteria. Virology (1999) 0.87
Prognostic factors in breast cancer--a pathological and immunological study of patients with stage 1 breast cancer. Eur J Surg Oncol (1987) 0.87
Resistance to nucleoside analogs of selective mutants of human immunodeficiency virus type 2 reverse transcriptase. J Virol (1995) 0.86
In vitro translation of a 180,000-dalton Rous sarcoma virus precursor polypeptide containing both the DNA polymerase and the group-specific antigens. Virology (1978) 0.86
The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1. J Biol Chem (1992) 0.85
Clathsterol, a novel anti-HIV-1 RT sulfated sterol from the sponge Clathria species. J Nat Prod (2001) 0.85
Analysis of the role of detergent mixtures on the crystallization of the reaction center of Photosystem II. Photosynth Res (2000) 0.85
A possible role for cysteine residues in the fidelity of DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. FEBS Lett (1992) 0.85
Crystal structures of KDOP synthase in its binary complexes with the substrate phosphoenolpyruvate and with a mechanism-based inhibitor. Biochemistry (2001) 0.84
Peyssonols A and B, two novel inhibitors of the reverse transcriptases of human immunodeficiency virus types 1 and 2. Arch Biochem Biophys (1995) 0.83
DNA-processing activities associated with the purified alpha, beta 2, and alpha beta molecular forms of avian sarcoma virus RNA-dependent DNA polymerase. J Virol (1982) 0.83
Mode of inhibition of HIV reverse transcriptase by 2-hexaprenylhydroquinone, a novel general inhibitor of RNA-and DNA-directed DNA polymerases. Biochem J (1997) 0.83
Mechanism of inhibition of HIV reverse transcriptase by toxiusol, a novel general inhibitor of retroviral and cellular DNA polymerases. Biochemistry (1995) 0.82
The use of anti-immunoglobulin for the immunoprecipitation of labeled proteins from tissue homogenates. Anal Biochem (1974) 0.82
Protein-induced, previously unidentified twin form of calcite. Proc Natl Acad Sci U S A (2007) 0.81
Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors. AIDS Res Hum Retroviruses (1994) 0.81
On the mechanism of glucose-6-phosphate dehydrogenase regulation in mouse liver. 2. Purification and properties of the mouse-liver enzyme. Eur J Biochem (1974) 0.81
The fidelity of misinsertion and mispair extension throughout DNA synthesis exhibited by mutants of the reverse transcriptase of human immunodeficiency virus type 2 resistant to nucleoside analogs. Eur J Biochem (1997) 0.81
Purification and partial characterization of a protein kinase from the Prague-C strain of Rous sarcoma virus. Virology (1979) 0.80
New co-metabolites of the streptazolin pathway. J Nat Prod (2001) 0.80
The catalytic properties of the reverse transcriptase of the lentivirus equine infectious anemia virus. Eur J Biochem (1994) 0.80
DNA synthesis exhibited by the reverse transcriptase of mouse mammary tumor virus: processivity and fidelity of misinsertion and mispair extension. Eur J Biochem (1998) 0.80
Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus. Biochem Biophys Res Commun (1993) 0.80
Mutagenesis of Gln294 of the reverse transcriptase of human immunodeficiency virus type-2 and its effects on the ribonuclease H activity. FEBS Lett (2008) 0.79
EPR and ENDOR studies of the water oxidizing complex of Photosystem II. Photosynth Res (1996) 0.78
3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. Arch Biochem Biophys (1994) 0.78
The carotenoid halocynthiaxanthin: a novel inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. Arch Biochem Biophys (1992) 0.78
RNA-dependent DNA polymerase of an endogenous type C virus of mice: purification and partial characterization. J Virol (1980) 0.78
Interaction of the reverse transcriptase of human immunodeficiency virus type 1 with DNA. Biochemistry (1994) 0.78
Hexaprenoid hydroquinones, novel inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. J Nat Prod (1993) 0.77
Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nucleoside inhibitors. FEBS Lett (1994) 0.77
Photoinactivation of photosystem II and degradation of the D 1 protein are reduced in a cytochrome b6/f-less mutant of Chlamydomonas reinhardtii. Z Naturforsch C (1990) 0.77
The interaction of the reverse transcriptase of human immunodeficiency virus type 1 with 3'-terminally mispaired DNA. Arch Biochem Biophys (1996) 0.76
Linker proteins enable ultrafast excitation energy transfer in the phycobilisome antenna system of Thermosynechococcus vulcanus. Photochem Photobiol Sci (2015) 0.76
Synthesis of naphthalenesulfonic acid small molecules as selective inhibitors of the DNA polymerase and ribonuclease H activities of HIV-1 reverse transcriptase. J Med Chem (1994) 0.75
Expression of the human immunodeficiency virus in Escherichia coli: chemotherapy. Important Adv Oncol (1989) 0.75
Crystallization of dimers of the manganese-stabilizing protein of Photosystem II. Photosynth Res (2000) 0.75
Evidence of additional excitation energy transfer pathways in the phycobiliprotein antenna system of Acaryochloris marina. Photochem Photobiol Sci (2015) 0.75
Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro. AIDS Res Hum Retroviruses (1992) 0.75
Structural polypeptide composition of a murine myeloma (MOPC-315) type C retrovirus. Biochem Biophys Res Commun (1981) 0.75
Regulation of Rous sarcoma virus RNA-dependent DNA polymerase isoenzymes by in vitro phosphorylation-dephosphorylation. Arch Biochem Biophys (1982) 0.75
Evaluation of factors responsible for the inability of insulin to antagonize lipolysis due to high concentrations of catecholamines. Biochem Biophys Res Commun (1982) 0.75
Hamster endogenous retrovirus (HaER)--distinct properties of structural proteins and DNA polymerase. Arch Virol (1983) 0.75